AXL and hepatocellular carcinoma: Compared with this group, the low Axl/low LC3 group (0%, 40.0%, 77.1% and 100%, respectively), high Axl/high LC3 group (18.8%, 56.9%, 75.7% and 81.5%, respectively) and high Axl/low LC3 group (23.1%, 70.1%, 90.0% and 100%, respectively) had significantly higher HCC recurrence rates (Figure 3A).